The Experts below are selected from a list of 58098 Experts worldwide ranked by ideXlab platform

Edward Topp - One of the best experts on this subject based on the ideXlab platform.

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

Kornelia Smalla - One of the best experts on this subject based on the ideXlab platform.

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

Pascal Simonet - One of the best experts on this subject based on the ideXlab platform.

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

James M Tiedje - One of the best experts on this subject based on the ideXlab platform.

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

  • editorial special section of fems microbiology ecology on the Environmental Dimension of antibiotic resistance
    FEMS Microbiology Ecology, 2016
    Co-Authors: Kornelia Smalla, Pascal Simonet, James M Tiedje, Edward Topp
    Abstract:

    The emergence of multi-drug-resistant human pathogens increasingly threatens the successful treatment of bacterial infections, and is now widely regarded as a global public health crisis. Antimicrobial resistance is a global problem, and managing resistance will require global action. As a start, many nations are now developing action plans to mitigate the development of antibiotic resistance. These action plans generally have three pillars, innovation, surveillance and stewardship; and are founded on the One Health concept. Namely, that humans and animals (companion and food animal producing) are inextricably linked to each other through the environment. Thus, research on the Environmental Dimension of antibiotic resistance has become a priority, within the broader context of maintaining the efficacy of antibiotics of crucial importance to human and animal medicine. This FEMS Microbiology Ecology thematic topic concerns recent progress made in our understanding of the Environmental Dimension of antibiotic resistance, here coined with the acronym EDAR. Most of the manuscripts were contributed by participants of the Third International Symposium on the Environmental Dimension of Antibiotic Resistance, EDAR3, held in Wernigerode, Germany in May 2015. The EDAR3 meeting follows EDAR2 held in Xiamen China in December 2013, and the original EDAR meeting held in Montebello Canada in March 2012. The consensus statement formulated by the participants of EDAR3 was ‘there are linkages between Environmental sources of antibiotic resistance and resistance in clinical pathogens, and human activity can increase, expand and mobilize Environmental genes responsible for resistance’. For more detail on the status of progress in the field there are several recent reviews that will be of interest (Finley et al . 2013; Durso and Cook 2014; Jechalke et al . 2014; Berendonk et al . 2015; Huijbers et al . 2015; Nesme and Simonet 2015; Williams-Nguyen et al. 2016). Here, we briefly … [↵][1]* Corresponding author: E-mail: kornelia.smalla{at}julius-kuehn.de [1]: #xref-corresp-1-1

Louis Brimacombe - One of the best experts on this subject based on the ideXlab platform.

  • Evaluating the Environmental Dimension of material efficiency strategies relating to the circular economy
    Sustainability (Switzerland), 2018
    Co-Authors: Stuart Walker, Nick Coleman, Nicola Collins, Louis Brimacombe
    Abstract:

    Material efficiency is a key element of new thinking to address the challenges of reducing impacts on the environment and of resource scarcity, whilst at the same time meeting service and functionality demands on materials. Directly related to material efficiency is the concept of the Circular Economy, which is based on the principle of optimising the utility embodied in materials and products through the life-cycle. Although materials such as steel, on account of high recycling rates at end-of-life, are amongst the most ‘circular’ of manufactured materials, significant opportunities for greater material efficiency exist, which are yet to be widely implemented. Life Cycle Assessment (LCA) is commonly used to assess the Environmental benefits of recovering and recycling materials through the manufacturing supply chain and at end-of-life. Using an example taken from renewable energy generation, this paper explores the correlation between product circularity and the Environmental case for strategies designed to improve material efficiency. An LCA-based methodology for accounting for the recovery and reuse of materials from the supply chain and at end-of-life is used as the basis for calculating the carbon footprint benefits of five material efficiency scenarios. The results are compared with a number of proposed material circularity indicators. Two conclusions from this exercise are that (i) LCA methodologies based around end-of-life approaches are well placed for quantifying the Environmental benefits of material efficiency and circular economy strategies and (ii) when applying indicators relating to the circularity of materials these should also be supported by LCA-based studies.